ArticleMediterranean journal of rheumatology2020
The Use of Infliximab (Remicade®) for the Treatment of Rheumatic Diseases at a Tertiary Center in Lebanon: A 17-Year Retrospective Chart Review.
Vicky Nahra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.